Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB755 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 II
22 119THCONGRESS
33 1
44 STSESSION S. 755
55 To facilitate the development of treatments for cancers, and for other
66 purposes.
77 IN THE SENATE OF THE UNITED STATES
88 FEBRUARY26, 2025
99 Mr. W
1010 ICKER(for himself and Ms. KLOBUCHAR) introduced the following bill;
1111 which was read twice and referred to the Committee on Finance
1212 A BILL
1313 To facilitate the development of treatments for cancers, and
1414 for other purposes.
1515 Be it enacted by the Senate and House of Representa-1
1616 tives of the United States of America in Congress assembled, 2
1717 SECTION 1. SHORT TITLE. 3
1818 This Act may be cited as the ‘‘Finn Sawyer Access 4
1919 to Cancer Testing Act’’. 5
2020 SEC. 2. COVERAGE OF CANCER DIAGNOSTIC AND LABORA-6
2121 TORY TESTS. 7
2222 (a) M
2323 EDICARE.— 8
2424 (1) C
2525 OVERAGE.—Section 1861 of the Social Se-9
2626 curity Act (42 U.S.C. 1395x) is amended— 10
2727 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
2828 ssavage on LAPJG3WLY3PROD with BILLS 2
2929 •S 755 IS
3030 (A) in subsection (s)(2)— 1
3131 (i) in subparagraph (JJ), by adding 2
3232 ‘‘and’’ at the end; and 3
3333 (ii) by adding at the end the following 4
3434 new subparagraph: 5
3535 ‘‘(KK) cancer diagnostic and laboratory tests 6
3636 (as defined in subsection (nnn)) furnished on or 7
3737 after the date that is 6 months after the date of the 8
3838 enactment of this subparagraph.’’; and 9
3939 (B) by adding at the end the following new 10
4040 subsection: 11
4141 ‘‘(nnn) C
4242 ANCERDIAGNOSTIC AND LABORATORY 12
4343 T
4444 ESTS.— 13
4545 ‘‘(1) I
4646 N GENERAL.—The term ‘cancer diag-14
4747 nostic and laboratory tests’ means— 15
4848 ‘‘(A) microarray analysis, DNA sequenc-16
4949 ing, RNA sequencing, whole-exome sequencing, 17
5050 and other forms of next-generation sequencing 18
5151 furnished and reported by a clinical laboratory 19
5252 (as defined in section 353(a) of the Public 20
5353 Health Service Act); and 21
5454 ‘‘(B) explanation and interpretation of any 22
5555 analysis or sequencing described in subpara-23
5656 graph (A); 24
5757 furnished to an individual diagnosed with cancer. 25
5858 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
5959 ssavage on LAPJG3WLY3PROD with BILLS 3
6060 •S 755 IS
6161 ‘‘(2) FREQUENCY.—When an individual test as 1
6262 described in paragraph (1) reports out the same ge-2
6363 netic content, it may only be furnished with respect 3
6464 to an individual diagnosed with a cancer— 4
6565 ‘‘(A) once upon the diagnosis of such can-5
6666 cer; 6
6767 ‘‘(B) once upon any recurrence of such 7
6868 cancer; and 8
6969 ‘‘(C) as necessary for purposes of planning 9
7070 treatment or monitoring the progression of such 10
7171 cancer or the response of such cancer to treat-11
7272 ment.’’. 12
7373 (2) P
7474 AYMENT.—Section 1833 of the Social Se-13
7575 curity Act (42 U.S.C. 1395l) is amended— 14
7676 (A) in subsection (a)(1)— 15
7777 (i) by striking ‘‘and’’ before ‘‘(HH)’’; 16
7878 and 17
7979 (ii) by inserting the following before 18
8080 the semicolon: ‘‘, and (II) with respect to 19
8181 cancer diagnostic and laboratory tests (as 20
8282 defined in section 1861(nnn)), the amount 21
8383 paid shall be an amount equal to 80 per-22
8484 cent (or 100 percent, in the case of such 23
8585 tests for which payment is made on an as-24
8686 signment-related basis) of the lesser of the 25
8787 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
8888 ssavage on LAPJG3WLY3PROD with BILLS 4
8989 •S 755 IS
9090 actual charge for the test or the amount 1
9191 that would have been determined for such 2
9292 test under section 1834A had such test 3
9393 been a clinical diagnostic laboratory test;’’; 4
9494 and 5
9595 (B) in subsection (b)— 6
9696 (i) by striking ‘‘, and (13)’’ and in-7
9797 serting ‘‘(13)’’; and 8
9898 (ii) by striking ‘‘1861(n).’’ and insert-9
9999 ing ‘‘section 1861(n), and (14) such de-10
100100 ductible shall not apply with respect to 11
101101 cancer diagnostic and laboratory tests (as 12
102102 defined in section 1861(nnn))’’. 13
103103 (3) E
104104 XCLUSION MODIFICATION .—Section 14
105105 1862(a)(1) of the Social Security Act (42 U.S.C. 15
106106 1395y(a)(1)) is amended— 16
107107 (A) in subparagraph (O), by striking 17
108108 ‘‘and’’ at the end; 18
109109 (B) in subparagraph (P), by striking the 19
110110 semicolon and inserting ‘‘, and’’; and 20
111111 (C) by adding at the end the following new 21
112112 subparagraph: 22
113113 ‘‘(Q) in the case of cancer diagnostic and lab-23
114114 oratory tests (as defined in section 1861(nnn)), 24
115115 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
116116 ssavage on LAPJG3WLY3PROD with BILLS 5
117117 •S 755 IS
118118 which are performed more frequently than is covered 1
119119 under such section;’’. 2
120120 (b) M
121121 EDICAID.— 3
122122 (1) I
123123 NCLUSION AS MEDICAL ASSISTANCE .—Sec-4
124124 tion 1905(a) of the Social Security Act (42 U.S.C. 5
125125 1396d(a)) is amended— 6
126126 (A) in paragraph (31), by striking ‘‘and’’ 7
127127 at the end; 8
128128 (B) by redesignating paragraph (32) as 9
129129 paragraph (33); and 10
130130 (C) by inserting after paragraph (31) the 11
131131 following new paragraph: 12
132132 ‘‘(32) cancer diagnostic and laboratory tests (as 13
133133 defined in section 1861(nnn)); and’’. 14
134134 (2) M
135135 ANDATORY COVERAGE .—Section 15
136136 1902(a)(10)(A) of such Act is amended, in the mat-16
137137 ter preceding clause (i), by striking ‘‘and (30)’’ and 17
138138 inserting ‘‘(30), and (32)’’. 18
139139 (3) I
140140 NCLUSION IN BENCHMARK COVERAGE .— 19
141141 Section 1937(b)(5) of such Act is amended by in-20
142142 serting before the period at the end the following: ‘‘, 21
143143 and beginning January 1, 2027, coverage of cancer 22
144144 diagnostic and laboratory tests (as defined in section 23
145145 1861(nnn))’’. 24
146146 (4) E
147147 FFECTIVE DATE.— 25
148148 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
149149 ssavage on LAPJG3WLY3PROD with BILLS 6
150150 •S 755 IS
151151 (A) IN GENERAL.—The amendments made 1
152152 by this section shall apply with respect to items 2
153153 and services furnished on or after January 1, 3
154154 2027. 4
155155 (B) E
156156 XEMPTION FOR STATE LEGISLA -5
157157 TION.—In the case of a State plan under title 6
158158 XIX of the Social Security Act (42 U.S.C. 1396 7
159159 et seq.), or waiver of such plan, that the Sec-8
160160 retary of Health and Human Services deter-9
161161 mines requires State legislation in order for the 10
162162 respective plan to meet any requirement im-11
163163 posed by amendments made by this section, the 12
164164 respective plan shall not be regarded as failing 13
165165 to comply with the requirements of such title 14
166166 solely on the basis of its failure to meet such 15
167167 an additional requirement before the first day 16
168168 of the first calendar quarter beginning after the 17
169169 close of the first regular session of the State 18
170170 legislature that begins after the date of the en-19
171171 actment of this Act. For purposes of the pre-20
172172 vious sentence, in the case of a State that has 21
173173 a 2-year legislative session, each year of the ses-22
174174 sion shall be considered to be a separate regular 23
175175 session of the State legislature. 24
176176 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
177177 ssavage on LAPJG3WLY3PROD with BILLS 7
178178 •S 755 IS
179179 (c) CHIP.—Section 2103(c) of the Social Security 1
180180 Act (42 U.S.C. 1397cc(c)) is amended by adding at the 2
181181 end the following new paragraph: 3
182182 ‘‘(13) C
183183 OVERAGE OF CANCER DIAGNOSTIC AND 4
184184 LABORATORY TESTS.—Regardless of the type of cov-5
185185 erage elected by a State under subsection (a), begin-6
186186 ning January 1, 2025 child health assistance pro-7
187187 vided under such coverage for targeted low-income 8
188188 children and, in the case that the State elects to pro-9
189189 vide pregnancy-related assistance under such cov-10
190190 erage pursuant to section 2112, such pregnancy-re-11
191191 lated assistance for targeted low-income pregnant 12
192192 women (as defined in section 2112(d)), shall include 13
193193 coverage of cancer diagnostic and laboratory tests 14
194194 (as defined in section 1861(nnn)).’’. 15
195195 SEC. 3. EDUCATION AND AWARENESS PROGRAM ON 16
196196 GENOMIC TESTING. 17
197197 (a) I
198198 NGENERAL.—The Secretary of Health and 18
199199 Human Services, in coordination with the Director of the 19
200200 National Human Genome Research Institute, shall carry 20
201201 out an education and awareness program for physicians 21
202202 and the general public on what genomic testing is, how 22
203203 it can be used, and the role of genetic counselors. 23
204204 (b) C
205205 ANCER ANDMOLECULARDIAGNOSTICS.—The 24
206206 education and awareness program under subsection (a) 25
207207 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\S755.IS S755
208208 ssavage on LAPJG3WLY3PROD with BILLS 8
209209 •S 755 IS
210210 shall encourage the inclusion in graduate medical edu-1
211211 cation and continuing medical education (including for 2
212212 specialty oncology services) of education and training on 3
213213 the importance of molecular diagnostics at diagnosis and 4
214214 reoccurrence of cancer to detect mutations. 5
215215 Æ
216216 VerDate Sep 11 2014 01:17 Mar 19, 2025 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6301 E:\BILLS\S755.IS S755
217217 ssavage on LAPJG3WLY3PROD with BILLS